DOCSLIB.ORG

Figure 1: Overview of the Presented Stepwise Study Consisting of Three Major Components

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Figure 1: Overview of the Presented Stepwise Study Consisting of Three Major Components Method development METABRIC DATA and (1989 tumor and 144 normal samples) cancer progression model construction Identify cancer related genes Identify molecular using regression analysis and subtypes stochastic learning Identify genetically Construct a principal tree using homogeneous groups using graph modeling clustering analysis Construct a progression model of breast cancer Map clinical and genetic variables back onto models Construct a cancer progression Perform validation • Survival data model using TCGA RNA-Seq study on 25 datasets • Histological/molecular data (1176 tumor and 111 (5831 tumor samples) grade normal samples) • Somatic mutation rate Model validation • Genome instability index Map mutation data onto disease Estimate mutation rates progression paths using kernel regression Identify genes with significant Driver gene mutation Perform hypothesis changes in mutation incidence testing and FDR control identification along progression paths Figure 1: Overview of the presented stepwise study consisting of three major components. First, a comprehensive bioinformatics pipeline was developed and a progression model of breast cancer was constructed. Then, a large- scale validation study was performed to evaluate the validity of the constructed model. Finally, a cancer genome analysis, focusing primarily on the detection of cancer driver gene mutations, was conducted that demonstrated the utility of the progression model. The study incorporated extensive algorithm development (Online Methods) and the analysis of 27 breast cancer datasets for model construction and validation (Online Methods – Datasets) Cancer Related Principal Curve Progression Model Clustering Analysis Gene Identification! Formation Construction samples metastasis a b cluster/ c progression d subtype path normal genes dormant Figure 2: Overview of the bioinformatics pipeline for cancer progression modeling. a b d c 4 luminal tumors 1 5 3 Cluster ID Figure 3: Progression modeling analysis of breast cancer 1 performed on the METABRIC data (n = 2,133). (a) Principal 2 9 3 component (PC) analysis provided a general view of sample 4 distribution supported by the selected genes. To aid in 5 7 6 visualization, each sample was annotated by its PAM50 subtype 7 8 label, and mapped onto a principal tree (black line) in a three- 2 9 dimensional space. Supplementary Movie 1 provides a clearer 10 picture of data distribution. (b-d) Clustering analysis performed to 8 detect genetically homogenous tumor groups. (b) The optimal number of clusters was estimated to be ten by gap statistic. (c) Resampling-based consensus clustering analysis identified ten 10 6 -0.1−0.1 0.00 0.10.1 0.20.2 0.30.3 robust and stable clusters. The samples in the red box are Silhouette width Silhouette width si predominantly luminal A/B tumors. The consensus matrix clearly Average silhouette width : 0.07 showed that luminal tumors can be further refined, however, they do not form clear-cut clusters and have significant overlaps, particularly between adjacent nodes, suggesting that they may normal 0 normal 0 N-LA share a progression relationship. (d) The robustness of clustering e f assignment was assessed by silhouette width analysis that 10 classified 1,652 out of 1,989 tumor samples with a positive N-B 2 silhouette width. (e) A progression model of breast cancer built 4 from the METABRIC data. The analysis revealed four major progression paths, referred to as N-B (normal to basal), N-H 7 8 1 8 (normal through luminal A/B to HER2+), N-LB (normal through 3 N-H N-LB luminal A to the luminal B terminus), and N-LA (normal to the 3 luminal A terminus). Each model node represents an identified 6 cluster and the node size is proportional to the number of samples 2 in that cluster. Two connected 150nodes indicate a potential 1 progressive relationship, and the length of an edge connecting two Basal nodes is proportional to the distance between the two nodes 9 5 6 100 5 H2 measured along a progression path. The pie chart in each node LumA depicts the percentage of the samples in the node belonging to one LumB 7 of the five PAM50 subtypes. (f) A progression50 model built from the 4 N TCGA RNA-Seq data (n = 1,287).Sample Count The overall structure of the progression models constructed using0 the two independent datasets is almost identical. 12345678 Cluster ID Mapping mutations Estimating Determining statistical Mutation matrix onto progression path mutation rates significance a TP53 0.9 140 gene Mutation rate 0.8 Null model 1 metastasis 120 0.7 1 1 progression 100 0.6 path 80 0.5 average 1 0.4 Counts 60 test 1 sample Mutation Rate Mutation rate 0.3 statistic 40 0.2 1 normal 20 0.1 1 1 1 0 0 0.2 0.4 0.6 0.8 1 1.2 1.4 0 2 4 6 8 10 ProgressionProgression Distance distance Null statistics 0.35 b c 1 0.08 0.45 d e 0.07 0.3 0.4 0.8 0.06 0.25 0.35 0.6 0.05 0.2 0.3 0.04 0.25 0.15 0.4 Mutation Rate Mutation Rate Mutation Rate 0.03 Mutation Rate 0.2 0.1 0.02 0.2 0.15 0.05 0.01 0.1 0 0 0.2 0.4 0.6 0.8 1 1.2 1.4 0.2 0.4 0.6 0.8 1 1.2 1.4 0.2 0.4 0.6 0.8 1 1.2 1.4 0.2 0.4 0.6 0.8 1 1.2 1.4 Progression Distance Progression Distance Progression Distance Progression Distance TP53 0.2 ATP1A4 0.2 ZNF587 HAUS5 HIST1H2BC TP53 GATA3 0.15 TRIM42 0.15 ERBB2 DOCK11 MAP2K4 FOXA1 normal g CABYR ARID1A QSER1 MYO6 MLL3 ITSN2 NPAS4 ATP10B NCOR1 CDH1 0.1 N4BP2 0.1 ABCC1 PTPRD PTEN GPS2 LETM1 BBS9 CDH12 MED23 Mutation Rate Mutation Rate RP1 RUNX1 RB1 COL19A1 0.05 CTTNBP2 0.05 KIAA2022 ZMYM4 KIF21B CNTLN ERBB3 WSCD2 0 PEG3 KIAA2022 0 0.2 0.4 0.6 0.8 1 1.2 1.4 0.2 0.4 0.6 0.8 1 SF3B1 Progression Distance Progression Distance 0.3 f 0.8 HLA-DRB1 luminal A 0.75 basal 0.25 PIK3CA 13 genes 0.7 TP53 TP53 GATA3 0.2 MAP2K4 0.65 CBFB CTCF 0.6 0.15 ADAM29 TP53 GRHL2 0.55 luminal B MYB TGS1 0.5 14 genes Mutation Rate Mutation Rate 0.1 GNAS CDKN1B 0.45 HER2+ TBL1XR1 0.05 0.4 21 genes 0.35 0 0.2 0.4 0.6 0.4 0.6 0.8 Progression Distance Progression Distance Figure 5: Pseudo-time series analysis performed on the TCGA mutation data (n = 958) to identify gene mutations associated with cancer progression. Fifty one genes were found to have significant changes in their mutation incidences along progression paths (FDR<0.05). (a) Overview of the proposed MutationPattern method used to delineate the dynamic patterns of individual gene mutations along a progression path. (b-e) Four distinct mutation patterns were observed. Examples of each are depicted: (b) TTN, (c) TP53, (d) MLL3, and (e) CDH1. The red line depicts the estimated mutation rate, and blue lines were generated from null models built by assuming that the corresponding gene plays no role in cancer development. Each red or blue line in the bar above the figure represents the presence or absence of a mutation in a sample, respectively. The first and second broken lines in (e) indicate the locations where the N-H path intersects with the LA terminal and LB terminal, respectively. (f) Genes showing an upward mutation trend along the N-LA, N-LB, N-H and N-B progression paths. (g) Mapping of significantly progression-associated genes onto the TCGA model. Genes reported at the end of a path are those with an upward trend along the entire path. Genes with a bell-shaped pattern are marked at the bell-peak location. Genes associated with normal samples are those mutated more frequently than random chance, but do not have significant changes along any progression path. a Figure 4: Model validation analysis provided substantial support for the validity of the constructed progression models. (a) Disease-specific survival of ten breast cancer subgroups detected in the METABRIC data. A clear trend of worsening survival function was identified that was associated with progression along the four major malignant trajectories - normal to either basal (N-B path: node 10 to node 6), the luminal A side- ClusterID branch (N-LA path: node 2 to node 8), luminal B side-branch (N- LB path: node 2 through nodes 7, 3 to node 9), or to HER2+ (N- H path: node 2 through nodes 7, 3, 1, 5 to node 4). (b-d) Spearman’s rank correlation analysis of molecular grade, genome instability index, and overall mutation rate along the progression paths. The results aligned well with current theories of cancer evolution. Since the METABRIC data does not contain mutation information, mutation data analysis was performed on the TCGA data (see Figure 3f for the TCGA model). ● ● ● ● LumB ● Basal H2 LumA NL ● ●● 2 ● b ● ● R=0.82 Pvalue = 8.7e−282 ● R=0.91 Pvalue = 5.5e−108 ● R=0.65 Pvalue = 3.9e−110 ● ● ● 3 R = 0.89 Pvalue = 0 ● ●● ● ● ●● ● ● ● ● ● ● ● ● ●● ● ● ●● ● ● ●● ● ● ● ● ● ●● ● ● ● ● ●● ● ● ● ● ● ●●● ●● ●●● ● ● ● ● ● ● ● ●● ● ● ●● ● ●● ●●● ●● ●●●● ● ● ● ● ● ● ● ●●● ●● ● ● ● ●● ● ● ● ● ● ● ● ● ● ● ●● ● ●●●● ● ●● ● ● ● ● ● ● ● ● ● ● ●● ● ● ●●●● ●●● ● ●● ● ● ● ● ●●● ● ● ●●● ● ● ● ●● ● ● ● ● ● 2 ● ●● ● ● ●● ● ● 1 ●● ● ●●● ● ● ●●●● ● ●●●●●● ● ● ● ● ● ● ● ● ●● ● ●●● ●●● ● ● ●● ●● ● ● ●●● ● ● ● ● ● ● ● ● ●● ● ●● ● ● ● ●●●●●● ●● ●● ● ● ● ●● ●● 2 ● ● ●●●● ● ● ●●●● ● ● ●●●● ● ●●● ● ● ● ● ●● ● ●● ●● ● ●●● ● ● ● ●●● ● 2 ● ●● ●● ●●● ●● ● ● ● ● ● ● ● ●●●●●● ● ● ● ● ●●● ● ● ● ● ● ● ● ●● ● ●● ● ●● ●●● ● ●●● ●● ● ● ● ● ● ●● ●● ●● ●●● ● ●● ● ● ●●● ●●● ● ●● ●● ● ●● ●● ● ● ●● ● ● ● ●●● ● ● ●● ● ● ●● ●● ● ●● ● ● ● ● ● ●●● ●● ●●●● ● ●● ●●● ●● ● ● ●●● ●●● ●●● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ● ●● ●● ●●● ● ● ●● ●●●●●●● ● ● ●●● ● ●●●●● ● ● ●● ● ● ●● ●● ● ● ● ●●●●●● ●●●● ●● ● ● ● ● ● ●●● ●●●●● ● ●● ● ●● ●●●●●●● ● ● ●● ● ● ● ● ●●● ●● ● ●● ● 1 ● ●● ●● ●●●●●●● ● ●●● ● ● ● ● ● ●●●●● ● ●●● ● ● ● ● ●● ● ● ● ●● ●
Load more

Recommended publications
  • Anti-ATP1A4 / Na+ K+ Atpase Alpha 4 Antibody (ARG58367)
    Product datasheet [email protected] ARG58367 Package: 100 μl anti-ATP1A4 / Na+ K+ ATPase alpha 4 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ATP1A4 / Na+ K+ ATPase alpha 4 Tested Reactivity Ms, Rat Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name ATP1A4 / Na+ K+ ATPase alpha 4 Antigen Species Human Immunogen Recombinant fusion protein corresponding to aa. 1-90 of Human ATP1A4 (NP_653300.2). Conjugation Un-conjugated Alternate Names Sodium pump subunit alpha-4; Sodium/potassium-transporting ATPase subunit alpha-4; ATP1AL2; EC 3.6.3.9; ATP1A1; Na+ K+ ATPase alpha 4; Na K ATPase alpha 4; sodium potassium ATPase alpha 4; ATPase Na+ K+ alpha 4; ATPase Na K alpha 4; ATPase sodium potassium alpha 4 Application Instructions Application table Application Dilution WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Mouse testis Calculated Mw 114 kDa Observed Size 100 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/2 Note For laboratory research only, not for drug, diagnostic or other use.
    [Show full text]
  • Supplementary Table 2
    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Atp1a4 (NM 013734) Mouse Tagged ORF Clone – MR220827L4 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for MR220827L4 Atp1a4 (NM_013734) Mouse Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Atp1a4 (NM_013734) Mouse Tagged ORF Clone Tag: mGFP Symbol: Atp1a4 Vector: pLenti-C-mGFP-P2A-Puro (PS100093) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(MR220827). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_013734 ORF Size: 3096 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Atp1a4 (NM_013734) Mouse Tagged ORF Clone – MR220827L4 OTI Disclaimer: Due to the inherent nature of this plasmid, standard methods to replicate additional amounts of DNA in E. coli are highly likely to result in mutations and/or rearrangements. Therefore, OriGene does not guarantee the capability to replicate this plasmid DNA. Additional amounts of DNA can be purchased from OriGene with batch-specific, full-sequence verification at a reduced cost. Please contact our customer care team at [email protected] or by calling 301.340.3188 option 3 for pricing and delivery. The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g.
    [Show full text]
  • New Insights on the Mechanisms Affecting Fertility in Men with Non-Seminoma Testicular Cancer Before Cancer Therapy
    Original Article pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2020 Apr 38(2): 198-207 https://doi.org/10.5534/wjmh.180099 New Insights on the Mechanisms Affecting Fertility in Men with Non-Seminoma Testicular Cancer before Cancer Therapy Tania R. Dias1,2,3 , Ashok Agarwal1 , Peter N. Pushparaj4 , Gulfam Ahmad5 , Rakesh Sharma1 1American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA, 2Universidade da Beira Interior, Covilhã, Portugal, 3Department of Microscopy, Laboratory of Cell Biology, Institute of Biomedical Sciences Abel Salazar and Unit for Multidisciplinary Research in Biomedicine, University of Porto, Porto, Portugal, 4Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, Jeddah, Saudi Arabia, 5Division of Pathology, School of Medical Sciences, Sydney University, Sydney, Australia Purpose: Patients with non-seminoma testicular cancer (NSTC) cancer can be subfertile or infertile, and present reduced sperm quality, but the underlying mechanisms are unknown. The aim of this study was to compare the sperm proteome of patients with NSTC, who cryopreserved their sperm before starting cancer treatment, with that from healthy fertile men. Materials and Methods: Semen volume, sperm motility and sperm concentration were evaluated before the cryopreservation of samples from patients with NSTC (n=15) and the control group (n=15). Sperm proteomic analysis was performed by liquid chromatography-tandem mass spectrometry and the differentially expressed proteins (DEPs) between the two groups were identified using bioinformatic tools. Results: A total of 189 DEPs was identified in the dataset, from which five DEPs related to sperm function and fertilization were selected for validation by Western blot.
    [Show full text]
  • Clinical Significance of P‑Class Pumps in Cancer (Review)
    ONCOLOGY LETTERS 22: 658, 2021 Clinical significance of P‑class pumps in cancer (Review) SOPHIA C. THEMISTOCLEOUS1*, ANDREAS YIALLOURIS1*, CONSTANTINOS TSIOUTIS1, APOSTOLOS ZARAVINOS2,3, ELIZABETH O. JOHNSON1 and IOANNIS PATRIKIOS1 1Department of Medicine, School of Medicine; 2Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus; 3College of Medicine, Member of Qatar University Health, Qatar University, 2713 Doha, Qatar Received January 25, 2021; Accepted Apri 12, 2021 DOI: 10.3892/ol.2021.12919 Abstract. P‑class pumps are specific ion transporters involved Contents in maintaining intracellular/extracellular ion homeostasis, gene transcription, and cell proliferation and migration in all 1. Introduction eukaryotic cells. The present review aimed to evaluate the 2. Methodology role of P‑type pumps [Na+/K+ ATPase (NKA), H+/K+ ATPase 3. NKA (HKA) and Ca2+‑ATPase] in cancer cells across three fronts, 4. SERCA pump namely structure, function and genetic expression. It has 5. HKA been shown that administration of specific P‑class pumps 6. Clinical studies of P‑class pump modulators inhibitors can have different effects by: i) Altering pump func‑ 7. Concluding remarks and future perspectives tion; ii) inhibiting cell proliferation; iii) inducing apoptosis; iv) modifying metabolic pathways; and v) induce sensitivity to chemotherapy and lead to antitumor effects. For example, 1. Introduction the NKA β2 subunit can be downregulated by gemcitabine, resulting in increased apoptosis of cancer cells. The sarco‑ The movement of ions across a biological membrane is a endoplasmic reticulum calcium ATPase can be inhibited by crucial physiological process necessary for maintaining thapsigargin resulting in decreased prostate tumor volume, cellular homeostasis.
    [Show full text]
  • Comprehensive Analysis of the Expression of Sodium/Potassium-Atpase Α Subunits and Prognosis of Ovarian Serous Cystadenocarcinoma
    Comprehensive Analysis of the Expression of Sodium/Potassium-ATPase α Subunits and Prognosis of Ovarian Serous Cystadenocarcinoma Wei Huang Tumor Hospital of Harbin Medical University Yongjian Zhang Tumor Hospital of Harbin Medical University Ye Xu Tumor Hospital of Harbin Medical University Shaoyou Yang Tumor Hospital of Harbin Medical University Bing Li Tumor Hospital of Harbin Medical University Lan Huang Tumor Hospital of Harbin Medical University Ge Lou ( [email protected] ) Tumor Hospital of Harbin Medical University https://orcid.org/0000-0001-6617-4482 Primary research Keywords: Adenosine triphosphate, ovary, cystadenocarcinoma, gynecology, gene expression Posted Date: June 22nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-23702/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on July 14th, 2020. See the published version at https://doi.org/10.1186/s12935-020-01414-5. Page 1/21 Abstract Background: Ovarian serous cystadenocarcinoma (OSC) is the most common and lethal gynecological cancer in women worldwide; however, biomarkers to diagnose and predict prognosis of OSC remain limited. Therefore, the present study aimed to investigate whether sodium/potassium adenosine triphosphate (Na+/K+-ATP)ase α-subunits (ATP1As) are helpful diagnostic and prognostic markers of OSC. Methods: Gene expression data (RNA-Seq) of 376 patients with OSC were downloaded from The Cancer Genome Atlas (TCGA) program database. Additional databases used in our analysis included the Gene Expression Omnibus, International Cancer Genome Consortium, Genotype–Tissue Expression, the Human Protein Atlas, cBioPortal for Cancer Genomics, and Cancer Cell Line Encyclopedia.
    [Show full text]
  • Testis-Specific Isoform of Na/K-Atpase (ATP1A4)
    International Journal of Molecular Sciences Article Testis-Specific Isoform of Na/K-ATPase (ATP1A4) Interactome in Raft and Non-Raft Membrane Fractions from Capacitated Bovine Sperm Gayathri D. Rajamanickam 1, John P. Kastelic 2 and Jacob C. Thundathil 2,* 1 Department of Veterinary Clinical and Diagnostic Services, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada 2 Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada * Correspondence: [email protected]; Tel.: +1-403-220-8244 Received: 5 May 2019; Accepted: 16 May 2019; Published: 28 June 2019 Abstract: The plasma membrane of sperm contains highly dynamic lipid microdomains (rafts), which house signaling proteins with a role in regulating capacitation. We reported that ATP1A4, the testis-specific isoform of Na/K-ATPase, interacted with caveolin-1, Src, epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinases 1/2 (ERK1/2) in raft and non-raft domains of the plasma membrane of bovine sperm during capacitation. The objective of the present study was to use a proteomic approach to characterize the ATP1A4 interactome in rafts and non-rafts from capacitated bovine sperm. The non-raft interactome included hexokinase 1, plakophilin 1, desmoglein 1, 14-3-3 protein ζ/δ, cathepsin D and heat shock protein beta1 proteins exclusively, whereas glutathione S-transferase and annexin A2 were unique to raft interactome. However, a disintegrin and metalloprotease 32 (ADAM 32), histone H4, actin, acrosin, serum albumin and plakoglobin were identified in both raft and non-raft fractions of capacitated sperm. Based on gene ontology studies, these differentially interacted proteins were implicated in cell–cell adhesion, signal transduction, fertilization, metabolism, proteolysis and DNA replication, in addition to acting as transport/carrier and cytoskeletal proteins.
    [Show full text]
  • Supplementary Information Page
    Supplementary information page Criteria for inclusion of patient variants in the analysis 1 Figure e-1 Alignment of the four human Na,K-ATPase alpha subunits 2-3 Figure e-2 Conformation differences when Na+ or K+ ions are bound 4 Figure e-3 Color-coded conservation scores for ATP1A1 generated by ConSurf 5 Figure e-4 Milder and more severe ATP1A3 pathogenic variants in the P domain are similar 6 Figure e-5 ATP1A2 and ATP1A3 variants in the S domain are also similar 7 Table e-1 Variants in ATP1A1 with references 8 Table e-2 Variants in ATP1A2 with references 9-13 Table e-3 Variants in ATP1A3 with references 14-19 Table e-4 Variants excluded from the analysis with references 20-21 Criteria for inclusion of patient variants in the analysis All included variants were missense, except that deletions of single amino acids were included without prejudice because several were recurrent in ATP1A2 and ATP1A3. The few more complicated genetic variants, splice site variants, and premature stops were not considered. Variants were considered pathogenic if: 1) identical variants arose independently in two or more unrelated patients/families with similar symptoms; 2) variants caused alternative amino acid changes in a single codon, with symptoms on the spectrum; 3) variants occurred at the equivalent position in more than one paralog, with symptoms typical of that paralog; or 4) there was laboratory evidence of impairment of Na,K-ATPase activity or biosynthesis. Single-family variants not meeting those criteria were considered probably pathogenic if 1) variants were proven to be de novo with DNA from both parents, or 2) pedigree data showed segregation with only affected members of the family, and 3) were considered possibly pathogenic when there was minimal or ambiguous pedigree data.
    [Show full text]
  • Whole-Genome DNA Methylation and Hydroxymethylation Profiling for HBV-Related Hepatocellular Carcinoma
    INTERNATIONAL JOURNAL OF ONCOLOGY 49: 589-602, 2016 Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma CHAO YE*, RAN TAO*, QINGYI CAO, DANHUA ZHU, YINI WANG, JIE WANG, JUAN LU, ERMEI CHEN and LANJUAN LI State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, P.R. China Received March 18, 2016; Accepted May 13, 2016 DOI: 10.3892/ijo.2016.3535 Abstract. Hepatocellular carcinoma (HCC) is a common tions between them. Taken together, in the present study we solid tumor worldwide with a poor prognosis. Accumulating conducted the first genome-wide mapping of DNA methyla- evidence has implicated important regulatory roles of epigen- tion combined with hydroxymethylation in HBV-related HCC etic modifications in the occurrence and progression of HCC. and provided a series of potential novel epigenetic biomarkers In the present study, we analyzed 5-methylcytosine (5-mC) for HCC. and 5-hydroxymethylcytosine (5-hmC) levels in the tumor tissues and paired adjacent peritumor tissues (APTs) from Introduction four individual HCC patients using a (hydroxy)methylated DNA immunoprecipitation approach combined with deep Hepatocellular carcinoma (HCC), a common solid tumor, is sequencing [(h)MeDIP-Seq]. Bioinformatics analysis revealed the third most frequent cause of cancer-related death in the that the 5-mC levels in the promoter regions of 2796 genes and world. Hepatitis B virus (HBV) infection is the main cause of the 5-hmC levels in 507 genes differed significantly between HCC in China (1).
    [Show full text]
  • Research Article Complex and Multidimensional Lipid Raft Alterations in a Murine Model of Alzheimer’S Disease
    SAGE-Hindawi Access to Research International Journal of Alzheimer’s Disease Volume 2010, Article ID 604792, 56 pages doi:10.4061/2010/604792 Research Article Complex and Multidimensional Lipid Raft Alterations in a Murine Model of Alzheimer’s Disease Wayne Chadwick, 1 Randall Brenneman,1, 2 Bronwen Martin,3 and Stuart Maudsley1 1 Receptor Pharmacology Unit, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Suite 100, Baltimore, MD 21224, USA 2 Miller School of Medicine, University of Miami, Miami, FL 33124, USA 3 Metabolism Unit, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Suite 100, Baltimore, MD 21224, USA Correspondence should be addressed to Stuart Maudsley, [email protected] Received 17 May 2010; Accepted 27 July 2010 Academic Editor: Gemma Casadesus Copyright © 2010 Wayne Chadwick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Various animal models of Alzheimer’s disease (AD) have been created to assist our appreciation of AD pathophysiology, as well as aid development of novel therapeutic strategies. Despite the discovery of mutated proteins that predict the development of AD, there are likely to be many other proteins also involved in this disorder. Complex physiological processes are mediated by coherent interactions of clusters of functionally related proteins. Synaptic dysfunction is one of the hallmarks of AD. Synaptic proteins are organized into multiprotein complexes in high-density membrane structures, known as lipid rafts. These microdomains enable coherent clustering of synergistic signaling proteins.
    [Show full text]
  • Extracellular Vesicles and the Oviduct Function
    International Journal of Molecular Sciences Review Extracellular Vesicles and the Oviduct Function Emily A. Harris, Kalli K. Stephens and Wipawee Winuthayanon * Center for Reproductive Biology, School of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA; [email protected] (E.A.H.); [email protected] (K.K.S.) * Correspondence: [email protected]; Tel.: +1-509-335-8296 Received: 28 October 2020; Accepted: 3 November 2020; Published: 5 November 2020 Abstract: In mammals, the oviduct (or the Fallopian tube in humans) can be divided into the infundibulum (responsible for oocyte pick-up), ampulla (site of fertilization), isthmus (where preimplantation embryos develop), and uterotubal junction (where embryos transit to the uterus). The oviductal fluid, as well as extracellular vesicles produced from the oviduct epithelial cells, referred to as oEVs, have been shown to improve the fertilization process, prevent polyspermy, and aid in embryo development. oEVs contain molecular cargos (such as miRNAs, mRNAs, proteins, and lipids) that can be delivered and fuse to recipient cells. oEVs produced from the ampulla appear to be functionally distinct from those produced from the isthmus. In multiple species including mice, cats, dogs, pigs, and cows, oEVs can be incorporated into the oocytes, sperm, and embryos. In this review, we show the positive impact of oEVs on gamete function as well as blastocyst development and how they may improve embryo quality in in vitro conditions in an assisted reproductive technology setting for rodents, domestic animals, farm animals, and humans. Keywords: egg; embryo; extracellular vesicle; exosome; fallopian tube; microvesicle; oocyte; oviductosome; oviduct; sperm 1.
    [Show full text]